PERSONAL COVID-BP

Trial Objective: Personalised Electronic Record Supported Optimisation when Alone for Patients with Hypertension - Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic
Disease area: Cardiovascular
Status: Ended December 2021
Chief Investigator: Dr David Collier
Sponsor: Queen Mary University of London
Funder: INNOVATE-UK & Closed Loop Medicine Ltd.
NCT REF: NCT04559074

Study summary

This is a community-based trial with remote monitoring and medical management from the clinical team. Participants are assigned into two groups. Both groups will record blood pressure and COVID19 symptoms into an electronic diary for 3 months. In addition, one group will be given a study medication called amlodipine with the aim to personalise the dosage to achieve optimal blood pressure management. Both groups will receive teleconsultations with the study doctor. The study will be delivered remotely for all participants.  

Sample size and duration

The sample size is 1000 participants. The duration the participants will be on the study is 3 months. 

Participants must be aged 18 years and over with no upper limit and, will all have had a diagnosis of essential hypertension. 

Enquiries

For further information, please contact:

Rebecca James  
Email: rebecca.james@qmul.ac.uk 
Tel: +44(0) 20 7882 3499  

Dr David Collier
Tel: 07961 383925
Email: d.j.collier@qmul.ac.uk